BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 22663249)

  • 1. Microemulsions for oral administration and their therapeutic applications.
    Gibaud S; Attivi D
    Expert Opin Drug Deliv; 2012 Aug; 9(8):937-51. PubMed ID: 22663249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs.
    Gursoy RN; Benita S
    Biomed Pharmacother; 2004 Apr; 58(3):173-82. PubMed ID: 15082340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Docetaxel microemulsion for enhanced oral bioavailability: preparation and in vitro and in vivo evaluation.
    Yin YM; Cui FD; Mu CF; Choi MK; Kim JS; Chung SJ; Shim CK; Kim DD
    J Control Release; 2009 Dec; 140(2):86-94. PubMed ID: 19709639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and evaluation of ibuprofen-loaded microemulsion for improvement of oral bioavailability.
    Hu L; Yang J; Liu W; Li L
    Drug Deliv; 2011 Jan; 18(1):90-5. PubMed ID: 20942639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of excipients in successful development of self-emulsifying/microemulsifying drug delivery system (SEDDS/SMEDDS).
    Rahman MA; Hussain A; Hussain MS; Mirza MA; Iqbal Z
    Drug Dev Ind Pharm; 2013 Jan; 39(1):1-19. PubMed ID: 22372916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimized mixed oils remarkably reduce the amount of surfactants in microemulsions without affecting oral bioavailability of ibuprofen by simultaneously enlarging microemulsion areas and enhancing drug solubility.
    Chen Y; Tuo J; Huang H; Liu D; You X; Mai J; Song J; Xie Y; Wu C; Hu H
    Int J Pharm; 2015 Jun; 487(1-2):17-24. PubMed ID: 25841571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of novel amisulpride-loaded liquid self-nanoemulsifying drug delivery systems via dual tackling of its solubility and intestinal permeability.
    Gamal W; Fahmy RH; Mohamed MI
    Drug Dev Ind Pharm; 2017 Sep; 43(9):1530-1538. PubMed ID: 28447878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioavailability of seocalcitol II: development and characterisation of self-microemulsifying drug delivery systems (SMEDDS) for oral administration containing medium and long chain triglycerides.
    Grove M; Müllertz A; Nielsen JL; Pedersen GP
    Eur J Pharm Sci; 2006 Jun; 28(3):233-42. PubMed ID: 16650738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solid self-microemulsifying drug delivery system of ritonavir.
    Deshmukh A; Kulkarni S
    Drug Dev Ind Pharm; 2014 Apr; 40(4):477-87. PubMed ID: 23465049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microemulsions: a novel approach to enhanced drug delivery.
    Talegaonkar S; Azeem A; Ahmad FJ; Khar RK; Pathan SA; Khan ZI
    Recent Pat Drug Deliv Formul; 2008; 2(3):238-57. PubMed ID: 19075911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and evaluation of self-microemulsifying liquid and pellet formulations of curcumin, and absorption studies in rats.
    Setthacheewakul S; Mahattanadul S; Phadoongsombut N; Pichayakorn W; Wiwattanapatapee R
    Eur J Pharm Biopharm; 2010 Nov; 76(3):475-85. PubMed ID: 20659556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of cell viability and permeation enhancement in presence of lipid-based self-emulsifying drug delivery systems using Caco-2 cell model: Polysorbate 80 as the surfactant.
    Bu P; Ji Y; Narayanan S; Dalrymple D; Cheng X; Serajuddin AT
    Eur J Pharm Sci; 2017 Mar; 99():350-360. PubMed ID: 28024890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential of microemulsions in drug delivery and therapeutics: a patent review.
    Bali V; Bhavna ; Ali M; Baboota S; Ali J
    Recent Pat Drug Deliv Formul; 2008; 2(2):136-44. PubMed ID: 19075904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microemulsion systems containing bioactive natural oils: an overview on the state of the art.
    Xavier-Junior FH; Vauthier C; Morais AR; Alencar EN; Egito ES
    Drug Dev Ind Pharm; 2017 May; 43(5):700-714. PubMed ID: 27622950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microemulsion formulation for enhanced absorption of poorly soluble drugs. I. Prescription design.
    Kawakami K; Yoshikawa T; Moroto Y; Kanaoka E; Takahashi K; Nishihara Y; Masuda K
    J Control Release; 2002 May; 81(1-2):65-74. PubMed ID: 11992679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and bioavailability assessment of ramipril nanoemulsion formulation.
    Shafiq S; Shakeel F; Talegaonkar S; Ahmad FJ; Khar RK; Ali M
    Eur J Pharm Biopharm; 2007 May; 66(2):227-43. PubMed ID: 17127045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microemulsions: a potential drug delivery system.
    Ghosh PK; Murthy RS
    Curr Drug Deliv; 2006 Apr; 3(2):167-80. PubMed ID: 16611003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microemulsions as carriers for drugs and nutraceuticals.
    Spernath A; Aserin A
    Adv Colloid Interface Sci; 2006 Dec; 128-130():47-64. PubMed ID: 17229398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving oral bioavailability of metformin hydrochloride using water-in-oil microemulsions and analysis of phase behavior after dilution.
    Li Y; Song J; Tian N; Cai J; Huang M; Xing Q; Wang Y; Wu C; Hu H
    Int J Pharm; 2014 Oct; 473(1-2):316-25. PubMed ID: 25014370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of microemulsion of mitotane for improvement of oral bioavailability.
    Attivi D; Ajana I; Astier A; Demoré B; Gibaud S
    Drug Dev Ind Pharm; 2010 Apr; 36(4):421-7. PubMed ID: 19778161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.